Characteristics | Number | No. of patients | P value | |
---|---|---|---|---|
circAKT3high | circAKT3low | |||
Age(y) | ||||
< 60 | 62 | 34 | 28 | 0.283 |
≥ 60 | 43 | 19 | 24 | |
Gender | ||||
Male | 80 | 37 | 43 | 0.121 |
Female | 25 | 16 | 9 | |
Tumor size(cm) | ||||
< 3.5 | 56 | 21 | 35 | 0.004** |
≥ 3.5 | 49 | 32 | 17 | |
Histological grade | ||||
Well-moderately | 33 | 11 | 22 | 0.017* |
Poorly-signet | 72 | 42 | 30 | |
Clinical stage | ||||
II | 39 | 13 | 26 | 0.007** |
III | 66 | 40 | 26 | |
T classification | ||||
T1-T2 | 31 | 9 | 22 | 0.004** |
T3-T4 | 74 | 44 | 30 | |
N classification | ||||
N0 | 14 | 5 | 9 | 0.232 |
N1-N3 | 91 | 48 | 43 | |
Cisplatin chemosensitivity | ||||
Sensitive | 92 | 41 | 51 | 0.001** |
Resistant | 13 | 12 | 1 |